CME Group (NASDAQ:CME) Issues Quarterly Earnings Results

CME Group (NASDAQ:CME) issued its quarterly earnings data on Wednesday. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08, FiscalAI reports. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.96 earnings per share.

Here are the key takeaways from CME Group’s conference call:

• CME reported a strong second quarter, with revenue of more than $1.7 billion, adjusted operating margin of 69.5%, and adjusted diluted EPS of $2.99, while returning $1.2 billion to shareholders through dividends and buybacks.
• Trading activity remained robust, as Q2 average daily volume of 29.8 million contracts was the second-highest second quarter in CME history, open interest rose 8% year over year, and July volumes were running 18% ahead of last year.
• Market data revenue set another record at $238 million, extending the company’s streak to 33 consecutive quarters of year-over-year growth and reflecting continued demand for CME’s pricing and data products.
• Management emphasized a broad product innovation pipeline, including 24/7 crypto and gold trading, upcoming single-stock futures, a planned Treasury Link product, and a new Compute Futures market tied to AI/data-center demand.
• Executives spent much of the call arguing that perpetual futures are not a fit for CME’s institutional customer base, saying they create higher cost and risk than CME’s listed futures, while warning that equity perps could pose systemic risk.

CME Group Price Performance

CME Group stock opened at $249.24 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a one year low of $218.31 and a one year high of $329.16. The business has a fifty day moving average of $255.87 and a two-hundred day moving average of $281.51. The company has a market cap of $90.31 billion, a P/E ratio of 21.27, a price-to-earnings-growth ratio of 2.95 and a beta of 0.25.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were issued a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. CME Group’s dividend payout ratio (DPR) is 44.37%.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group reported Q2 earnings of $2.99 per share, ahead of estimates, while revenue of about $1.71 billion also topped forecasts; the beat was driven by resilient hedging demand and stronger equity index trading volumes. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, net income, and EPS, which supports the bullish reaction to the stock. CME Group jumps after Q2 earnings beat and strong trading activity
• Positive Sentiment: Market data revenue hit a record in the quarter, and overall trading volume remained robust, reinforcing the view that volatility and hedging demand are still driving CME’s core franchise. US Stock Market: CME shares jump 6% after Q2 profit beats estimates; strong hedging demand boosts results
• Neutral Sentiment: Investor chatter about potential perpetual futures products continues to create noise around the stock, but management says clients are not demanding them and analysts view the issue as unlikely to matter long term. CME’s Duffy Says Its Clients Aren’t Demanding Perpetual Futures
• Neutral Sentiment: The company is also preparing for a leadership transition with a new CEO appointment, which is more of a longer-term governance development than an immediate earnings catalyst.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CME shares. The Goldman Sachs Group decreased their price target on shares of CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a research note on Tuesday, June 30th. TD Cowen decreased their target price on shares of CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Weiss Ratings downgraded CME Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 13th. Finally, Morgan Stanley decreased their price objective on CME Group from $353.00 to $324.00 and set an “overweight” rating for the company in a research report on Friday, July 10th. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $292.12.

Insider Activity

In other news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares of the company’s stock, valued at $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard bought 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Large investors have recently added to or reduced their stakes in the business. Pinnacle Financial Partners Inc. boosted its position in CME Group by 2.0% during the third quarter. Pinnacle Financial Partners Inc. now owns 107,111 shares of the financial services provider’s stock worth $28,940,000 after acquiring an additional 2,108 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of CME Group during the 4th quarter worth $109,000. Truvestments Capital LLC boosted its holdings in shares of CME Group by 124.8% during the fourth quarter. Truvestments Capital LLC now owns 317 shares of the financial services provider’s stock worth $87,000 after purchasing an additional 176 shares during the last quarter. Rossby Financial LCC boosted its holdings in shares of CME Group by 29.0% during the fourth quarter. Rossby Financial LCC now owns 276 shares of the financial services provider’s stock worth $75,000 after purchasing an additional 62 shares during the last quarter. Finally, Johnson Financial Group Inc. grew its position in shares of CME Group by 15.9% in the third quarter. Johnson Financial Group Inc. now owns 445 shares of the financial services provider’s stock valued at $120,000 after purchasing an additional 61 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.